InvestorsObserver
×
News Home

Should You Hold Aptorum Group Ltd (APM) in Biotechnology Industry?

Thursday, August 18, 2022 12:12 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Hold Aptorum Group Ltd (APM) in Biotechnology Industry?

The 57 rating InvestorsObserver gives to Aptorum Group Ltd (APM) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 58 percent of stocks in the Biotechnology industry, APM’s 57 overall rating means the stock scores better than 57 percent of all stocks.

Overall Score - 57
APM has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on APM!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Aptorum Group Ltd Stock Today?

Aptorum Group Ltd (APM) stock is lower by -1.8% while the S&P 500 is higher by 0.24% as of 11:52 AM on Thursday, Aug 18. APM has fallen -$0.03 from the previous closing price of $1.67 on volume of 235,082 shares. Over the past year the S&P 500 has fallen -2.63% while APM has fallen -33.06%. APM lost -$0.71 per share the over the last 12 months. Click Here to get the full Stock Report for Aptorum Group Ltd stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App